154 related articles for article (PubMed ID: 38047307)
21. Andrographolide Ameliorates Diabetic Cardiomyopathy in Mice by Blockage of Oxidative Damage and NF-
Liang E; Liu X; Du Z; Yang R; Zhao Y
Oxid Med Cell Longev; 2018; 2018():9086747. PubMed ID: 30046380
[TBL] [Abstract][Full Text] [Related]
22. [Irisin Alleviates Inflammatory Injury in Diabetic Cardiomyopathy by Regulating NF-κB Pathway].
Zhang C; Huang J; Yang P; Liu X; Fan ZC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):545-551. PubMed ID: 37248582
[TBL] [Abstract][Full Text] [Related]
23. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
24. BNP protects against diabetic cardiomyopathy by promoting Opa1-mediated mitochondrial fusion via activating the PKG-STAT3 pathway.
Chang P; Zhang X; Zhang J; Wang J; Wang X; Li M; Wang R; Yu J; Fu F
Redox Biol; 2023 Jun; 62():102702. PubMed ID: 37116257
[TBL] [Abstract][Full Text] [Related]
25. Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds.
Rabbani PS; Ellison T; Waqas B; Sultan D; Abdou S; David JA; Cohen JM; Gomez-Viso A; Lam G; Kim C; Thomson J; Ceradini DJ
Diabetes Res Clin Pract; 2018 May; 139():11-23. PubMed ID: 29476889
[TBL] [Abstract][Full Text] [Related]
26. Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy.
Hu L; Ding M; Tang D; Gao E; Li C; Wang K; Qi B; Qiu J; Zhao H; Chang P; Fu F; Li Y
Theranostics; 2019; 9(13):3687-3706. PubMed ID: 31281507
[TBL] [Abstract][Full Text] [Related]
27. Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I
Liao HH; Zhu JX; Feng H; Ni J; Zhang N; Chen S; Liu HJ; Yang Z; Deng W; Tang QZ
Oxid Med Cell Longev; 2017; 2017():8370593. PubMed ID: 29147465
[TBL] [Abstract][Full Text] [Related]
28. Obeticholic acid protects against diabetic cardiomyopathy by activation of FXR/Nrf2 signaling in db/db mice.
Wu H; Liu G; He Y; Da J; Xie B
Eur J Pharmacol; 2019 Sep; 858():172393. PubMed ID: 31085240
[TBL] [Abstract][Full Text] [Related]
29. Myricitrin Alleviates Oxidative Stress-induced Inflammation and Apoptosis and Protects Mice against Diabetic Cardiomyopathy.
Zhang B; Shen Q; Chen Y; Pan R; Kuang S; Liu G; Sun G; Sun X
Sci Rep; 2017 Mar; 7():44239. PubMed ID: 28287141
[TBL] [Abstract][Full Text] [Related]
30. Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway.
Li F; Hu Z; Huang Y; Zhan H
J Cardiothorac Surg; 2023 Jul; 18(1):223. PubMed ID: 37430319
[TBL] [Abstract][Full Text] [Related]
31. Curcumin activates Nrf2/HO-1 signaling to relieve diabetic cardiomyopathy injury by reducing ROS in vitro and in vivo.
Wu X; Zhou X; Lai S; Liu J; Qi J
FASEB J; 2022 Sep; 36(9):e22505. PubMed ID: 35971779
[TBL] [Abstract][Full Text] [Related]
32. miR-503 Is Involved in the Protective Effect of Phase II Enzyme Inducer (CPDT) in Diabetic Cardiomyopathy via Nrf2/ARE Signaling Pathway.
Miao Y; Wan Q; Liu X; Wang Y; Luo Y; Liu D; Lin N; Zhou H; Zhong J
Biomed Res Int; 2017; 2017():9167450. PubMed ID: 29404371
[TBL] [Abstract][Full Text] [Related]
33. Blockage of DCLK1 in cardiomyocytes suppresses myocardial inflammation and alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic mice.
Ji L; Yang X; Jin Y; Li L; Yang B; Zhu W; Xu M; Wang Y; Wu G; Luo W; Lee K; Liang G
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166900. PubMed ID: 37778481
[TBL] [Abstract][Full Text] [Related]
34. Never in mitosis gene A-related kinase-6 deficiency deteriorates diabetic cardiomyopathy via regulating heat shock protein 72.
Shao S; Xiao L; Jia M; Zhang C; Zhao G; Yao R; Wang X; Gao L
J Mol Med (Berl); 2023 Apr; 101(4):419-430. PubMed ID: 36867206
[TBL] [Abstract][Full Text] [Related]
35. Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways.
Yao J; Li Y; Jin Y; Chen Y; Tian L; He W
Int Immunopharmacol; 2021 Jul; 96():107728. PubMed ID: 33971494
[TBL] [Abstract][Full Text] [Related]
36. Ferulic acid attenuates high glucose-induced MAM alterations via PACS2/IP3R2/FUNDC1/VDAC1 pathway activating proapoptotic proteins and ameliorates cardiomyopathy in diabetic rats.
Salin Raj P; Nair A; Preetha Rani MR; Rajankutty K; Ranjith S; Raghu KG
Int J Cardiol; 2023 Feb; 372():101-109. PubMed ID: 36481261
[TBL] [Abstract][Full Text] [Related]
37. Sinapic acid ameliorates cardiac dysfunction and cardiomyopathy by modulating NF-κB and Nrf2/HO-1 signaling pathways in streptozocin induced diabetic rats.
Raish M; Ahmad A; Bin Jardan YA; Shahid M; Alkharfy KM; Ahad A; Ansari MA; Abdelrahman IA; Al-Jenoobi FI
Biomed Pharmacother; 2022 Jan; 145():112412. PubMed ID: 34768051
[TBL] [Abstract][Full Text] [Related]
38. Quercetin Inhibits Pyroptosis in Diabetic Cardiomyopathy through the Nrf2 Pathway.
Wei Z; Jing Z; Pinfang K; Chao S; Shaohuan Q
J Diabetes Res; 2022; 2022():9723632. PubMed ID: 36624860
[TBL] [Abstract][Full Text] [Related]
39. LncDACH1 promotes mitochondrial oxidative stress of cardiomyocytes by interacting with sirtuin3 and aggravates diabetic cardiomyopathy.
Zhang Q; Li D; Dong X; Zhang X; Liu J; Peng L; Meng B; Hua Q; Pei X; Zhao L; Hu X; Zhang Y; Pan Z; Lu Y; Yang B
Sci China Life Sci; 2022 Jun; 65(6):1198-1212. PubMed ID: 34668131
[TBL] [Abstract][Full Text] [Related]
40. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling.
Gao L; Liu Y; Guo S; Xiao L; Wu L; Wang Z; Liang C; Yao R; Zhang Y
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3322-3338. PubMed ID: 30031228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
